Hearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Otology and Neurotology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MAO.0000000000001254PMID 27779563PMCID PMC5154844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro and in vivo pharmacokinetic study of a dexamethasone-releasing silicone for cochlear implants

  2016cited by this paper
• Intratympanic corticosteroids injections: a systematic review of literature

  2016cited by this paper
• Electrode array-eluted dexamethasone protects against electrode insertion trauma induced hearing and hair cell losses, damage to neural elements, increases in impedance and fibrosis: A dose response study.

  2016influential reference
• Effects of a dexamethasone-releasing implant on cochleae: A functional, morphological and pharmacokinetic study.

  2015cited by this paper
• Dose Effect of Intratympanic Dexamethasone for Idiopathic Sudden Sensorineural Hearing Loss: 24 mg/mL Is Superior to 10 mg/mL

  2015cited by this paper
• Comparison of steroid administration methods in patients with idiopathic sudden sensorineural hearing loss: a retrospective observational study

  2015cited by this paper
• Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: analysis of an RCT and material drawn from the Swedish national database

  2015cited by this paper
• A Prospective, Multi-Centered Study of the Treatment of Idiopathic Sudden Sensorineural Hearing Loss With Combination Therapy Versus High-Dose Prednisone Alone: A 139 Patient Follow-up

  2014cited by this paper
• Efficacy and Safety of AM-111 in the Treatment of Acute Sensorineural Hearing Loss: A Double-Blind, Randomized, Placebo-Controlled Phase II Study

  2014cited by this paper
• Gene Expression Pattern after Insertion of Dexamethasone-Eluting Electrode into the Guinea Pig Cochlea

  2014cited by this paper
• Intratympanic steroid injection as a salvage treatment for sudden sensorineural hearing loss

  2014cited by this paper
• Intratympanale Dexamethasongabe

  2013cited by this paper
• Combined Intratympanic and Systemic Steroid Therapy for Poor-Prognosis Sudden Sensorineural Hearing Loss

  2013cited by this paper
• Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy

  2013cited by this paper
• Comparison of Intratympanic Steroid Injection, Hyperbaric Oxygen and Combination Therapy in Refractory Sudden Sensorineural Hearing Loss

  2013cited by this paper
• Gentamicin Concentration Gradients in Scala Tympani Perilymph following Systemic Applications

  2013cited by this paper
• Efficacy of 3 Different Steroid Treatments for Sudden Sensorineural Hearing Loss

  2013cited by this paper
• Intratympanic steroids as primary initial treatment of idiopathic sudden sensorineural hearing loss

  2013cited by this paper
• Dexamethasone eluting cochlear implant: Histological study in animal model

  2013influential reference
• Intratympanic dexamethasone perfusion versus injection for treatment of refractory sudden sensorineural hearing loss

  2013cited by this paper
• Therapeutic Efficacy of the Combination of Intratympanic Methylprednisolone and Oral Steroid for Idiopathic Sudden Deafness

  2013cited by this paper
• Perilymph Pharmacokinetics of Markers and Dexamethasone Applied and Sampled at the Lateral Semi-Circular Canal

  2012cited by this paper
• Analysis of frequency loss as a prognostic factor in idiopathic sensorineural hearing loss

  2012cited by this paper
• Marker entry into vestibular perilymph via the stapes following applications to the round window niche of guinea pigs.

  2012cited by this paper
• Noninvasive intratympanic dexamethasone treatment for sudden sensorineural hearing loss

  2012cited by this paper
• Outcomes of Intratympanic Gentamicin Injection to Treat Ménière’s Disease

  2012cited by this paper
• Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy

  2012cited by this paper
• Are intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice

  2012cited by this paper
• Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases

  2011cited by this paper
• Simultaneous versus Subsequent Intratympanic Dexamethasone for Idiopathic Sudden Sensorineural Hearing Loss

  2011cited by this paper
• Intratympanic Versus Intravenous Delivery of Dexamethasone and Dexamethasone Sodium Phosphate to Cochlear Perilymph

  2011cited by this paper
• The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss

  2011cited by this paper
• Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial.

  2011cited by this paper
• Intratympanic methylprednisolone as first-line therapy in sudden sensorineural hearing loss: preliminary results from a case–control series

  2011cited by this paper
• Treatment of sudden sensorineural hearing loss with transtympanic injection of steroids as single therapy: a randomized clinical study

  2011cited by this paper
• Direct Entry of Gadolinium into the Vestibule Following Intratympanic Applications in Guinea Pigs and the Influence of Cochlear Implantation

  2011cited by this paper
• Intratympanic Dexamethasone/Hyaluronic Acid Mix as an Adjunct to Intravenous Steroid and Vasoactive Treatment in Patients With Severe Idiopathic Sudden Sensorineural Hearing Loss

  2011cited by this paper
• Intratympanic Dexamethasone Is an Effective Method as a Salvage Treatment in Refractory Sudden Hearing Loss

  2011cited by this paper
• Combined Intratympanic and Systemic Use of Steroids for Idiopathic Sudden Sensorineural Hearing Loss

  2011cited by this paper
• Clinical Practice Guideline: Sudden Hearing Loss

  2011cited by this paper
• Clinical Practice Guideline

  2011cited by this paper
• Intratympanic Methylprednisolone as Rescue Therapy in Sudden Sensorineural Hearing Loss

  2010cited by this paper
• Assessment of diagnostic approaches to idiopathic sudden sensorineural hearing loss and their influence on treatment and outcome

  2010cited by this paper
• Intratympanic injection with dexamethasone for sudden sensorineural hearing loss

  2010cited by this paper
• Intratympanic Steroids in Severe to Profound Sudden Sensorineural Hearing Loss as Salvage Treatment

  2010cited by this paper
• Daily Short-Term Intratympanic Dexamethasone Treatment Alone as an Initial or Salvage Treatment for Idiopathic Sudden Sensorineural Hearing Loss

  2010cited by this paper
• Assessment of diagnostic approaches to idiopathic sudden sensorineural hearing loss and their influence on treatment and outcome

  2010cited by this paper
• Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss

  2010cited by this paper
• Distribution of Dexamethasone and Preservation of Inner Ear Function following Intratympanic Delivery of a Gel-Based Formulation

  2010cited by this paper
• Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL

  2009cited by this paper
• Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes

  2009cited by this paper
• Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy

  2009cited by this paper
• Rapid clearance of methylprednisolone after intratympanic application in humans. Comment on: Bird PA, Begg EJ, Zhang M, et al. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 2007;28:1124-30.

  2008cited by this paper
• Can Intratympanic Dexamethasone Added to Systemic Steroids Improve Hearing Outcome in Patients With Sudden Deafness?

  2008cited by this paper
• Combination Therapy (Intratympanic Dexamethasone + High-Dose Prednisone Taper) for the Treatment of Idiopathic Sudden Sensorineural Hearing Loss

  2008cited by this paper
• Clinical practice. Idiopathic sudden sensorineural hearing loss.

  2008cited by this paper
• Dexamethasone Concentration Gradients Along Scala Tympani After Application to the Round Window Membrane

  2008cited by this paper
• Regulation of ENaC‐mediated sodium transport by glucocorticoids in Reissner's membrane epithelium

  2008cited by this paper
• Dependence of Hearing Changes on the Dose of Intratympanically Applied Gentamicin: A Meta‐Analysis Using Mathematical Simulations of Clinical Drug Delivery Protocols

  2008cited by this paper
• RAPID CLEARANCE OF METHYLPREDNISOLONE AFTER INTRATYMPANIC APPLICATION IN HUMANS: IN REPLY

  2008cited by this paper
• Prognostic Model for Predicting Hearing Recovery in Idiopathic Sudden Sensorineural Hearing Loss

  2008cited by this paper
• Hearing outcome of sudden sensorineural hearing loss: Long-term follow-up

  2007cited by this paper
• Comparison of Pure-Tone Audiometry Analysis in Sudden Hearing Loss Studies: Lack of Agreement for Different Outcome Measures

  2007cited by this paper
• Idiopathic sudden sensorineural hearing loss: results drawn from the Swedish national database

  2007cited by this paper
• Intratympanic Steroids for Treatment of Sudden Hearing Loss after Failure of Intravenous Therapy

  2007cited by this paper
• In Vivo Estimates of the Position of Advanced Bionics Electrode Arrays in the Human Cochlea

  2007cited by this paper
• Intratympanic Versus Intravenous Delivery of Methylprednisolone to Cochlear Perilymph

  2007cited by this paper
• Glucocorticoid regulation of genes in the amiloride-sensitive sodium transport pathway by semicircular canal duct epithelium of neonatal rat.

  2006cited by this paper
• Efficacy of steroid injection on idiopathic sudden sensorineural hearing loss

  2006cited by this paper
• Prognostic Factors in Sudden Sensorineural Hearing Loss: Our Experience and a Review of the Literature

  2006cited by this paper
• Comparison of Intratympanic and Intravenous Dexamethasone Treatment on Sudden Sensorineural Hearing Loss with Diabetes

  2006cited by this paper
• Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids

  2005cited by this paper
• Intratympanic Corticosteroids for Sudden Idiopathic Sensorineural Hearing Loss

  2005cited by this paper
• Transtympanic corticoid therapy for acute profound hearing loss

  2005cited by this paper
• Intratympanic steroids for sensorineural hearing loss.

  2004cited by this paper
• Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties.

  2004cited by this paper
• Oral Steroid Treatment of Sudden Sensorineural Hearing Loss: A Ten Year Retrospective Analysis

  2003cited by this paper
• Prognosis and treatment of sudden sensorineural hearing loss.

  1996cited by this paper
• Outcome of sudden deafness with and without vertigo

  1993cited by this paper
• Antimitogenic effects of dexamethasone in chemically transformed mouse fibroblasts.

  1991cited by this paper
• A cochlear frequency-position function for several species--29 years later.

  1990cited by this paper
• Sudden hearing loss: Eight years' experience and suggested prognostic table

  1984cited by this paper
• Natural History of Sudden Sensorineural Hearing Loss

  1977cited by this paper
• EFFECT OF STEROIDS ON GROWTH OF MOUSE FIBROBLASTS IN VITRO.

  1965cited by this paper

• Analysis of the Reasons for Poor Prognosis in Severe to Profound Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis

  2025cites this paper
• Advances in auricular drug delivery for the management of different otitic conditions.

  2025cites this paper
• Current Role of the Nonsteroid Treatment of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL): A Narrative Review

  2025cites this paper
• Current and emerging approaches to cochlear immunosuppression with translation to human inner ear stem cell therapy: A systematic review

  2025cites this paper
• Intratympanic steroid administration and predictors of recovery in sudden sensorineural hearing loss

  2025cites this paper
• Precision and prediction matter: investigating hearing recovery measurements and prognosis in sudden sensorineural hearing loss

  2025cites this paper
• Stellenwert der intratympanalen Glukokortikoidtherapie in der Behandlung des Hörsturzes

  2024cites this paper
• Die HODOKORT-Studie und aktuelle Aspekte der Hörsturztherapie mit Glukokortikoiden

  2024cites this paper
• Plasma Concentration as a Proxy for Perilymph Drug Levels: Preclinical and Clinical Dexamethasone Measures with a Long-Acting Formulation for Precise Delivery to the Round Window Membrane

  2024cites this paper
• Protocol for a multicentre randomised controlled trial of STeroid Administration Routes For Idiopathic Sudden sensorineural Hearing loss: The STARFISH trial

  2023influential citation
• Results of a New Treatment Protocol for Sudden Sensorineural Hearing Loss Using Betamethasone for Intratympanic Therapy

  2023cites this paper
• Spontaneous recovery rate of idiopathic sudden sensorineural hearing loss: A systematic review and meta‐analysis

  2023cites this paper
• Prognostic factors in elderly patients after an intra-tympanic steroid injection for idiopathic sudden sensorineural hearing loss.

  2022cites this paper
• Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of dexamethasone to the inner ear

  2022cites this paper
• Optimal timing of salvage intratympanic steroids in idiopathic sudden sensorineural hearing loss

  2022cites this paper
• Intratympanic corticosteroids for sudden sensorineural hearing loss

  2022cites this paper
• Idiopathic sudden sensorineural hearing loss: A critique on corticosteroid therapy.

  2022cites this paper
• Effects of oral N-acetylcysteine combined with oral prednisolone on idiopathic sudden sensorineural hearing loss

  2022cites this paper
• Probability of clinically significant hearing recovery following salvage intratympanic steroids for sudden sensorineural hearing loss in the ‘real world’

  2022cites this paper
• Clinical Profile of Patients With Unilateral Sudden Sensorineural Hearing Loss: Correlation With Hearing Prognosis

  2021cites this paper
• Comparison of two different intratympanic corticosteroid injection protocols as salvage treatments for idiopathic sudden sensorineural hearing loss

  2021cites this paper
• Evaluation and comparison of the efficacy of long-acting betamethasone and dexamethasone as injections in the treatment of idiopathic sudden hearing loss.

  2021cites this paper
• N-Acetylcysteine Combined With Dexamethasone Treatment Improves Sudden Sensorineural Hearing Loss and Attenuates Hair Cell Death Caused by ROS Stress

  2021cites this paper
• Combined Intratympanic and Systemic Steroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss

  2021cites this paper
• Research progress in refractory sudden hearing loss: steroid therapy

  2020cites this paper
• Impacts of different methylprednisolone administration routes in patients with sudden hearing loss or Meniere’s disease

  2020cites this paper
• Bringt die Abdeckung des ovalen Fensters zusätzlich zum runden Fenster bei der Reservetherapie der akuten idiopathischen Ertaubung einen Vorteil?

  2020cites this paper
• Immune Response After Cochlear Implantation

  2020cites this paper
• Intratympanic application of triamcinolone in sudden hearing loss—radiologic anatomy in cone beam CT and its’ correlation to clinical outcome

  2020cites this paper
• Steroid Nomenclature in Inner Ear Therapy.

  2020cites this paper
• Comparison of Hearing Preservation Outcomes Using Extended Versus Single-Dose Steroid Therapy in Cochlear Implantation.

  2020cites this paper
• Comparison of the Pharmacokinetic Properties of Triamcinolone and Dexamethasone for Local Therapy of the Inner Ear

  2019cites this paper
• Update on consensus on diagnosis and treatment of idiopathic sudden sensorineural hearing loss

  2019cites this paper
• Sudden sensorineural hearing loss – A contemporary review of management issues

  2019cites this paper
• Clinical Practice Guideline: Sudden Hearing Loss (Update)

  2019cites this paper
• Efficacy of Intratympanic Corticosteroid as a Salvage Treatment in Idiopathic Sudden Sensorineural Hearing Loss

  2019cites this paper
• Improving Clinical Outcomes in Cochlear Implantation Using Glucocorticoid Therapy: A Review.

  2019cites this paper
• Round Window Niche Drilling with Intratympanic Steroid Is a Salvage Therapy of Sudden Hearing Loss

  2019influential citation
• Update on consensus on diagnosis and treatment of idiopathic sudden sensorineural hearing loss.

  2019cites this paper
• Efficacy of intratympanic corticosteroid as a salvage treatment in idiopathic sudden sensorineural hearing loss.

  2019cites this paper
• Intratympanic steroid use for idiopathic sudden sensorineural hearing loss: current otolaryngology practice in Germany and Austria

  2018cites this paper
• Otic drug delivery systems: formulation principles and recent developments

  2018cites this paper
• Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications

  2018cites this paper
• Hearing Changes After Intratympanic Steroids for Secondary (Salvage) Therapy of Sudden Hearing Loss: A Meta-Analysis Using Mathematical Simulations of Drug Delivery Protocols.

  2018cites this paper
• Dexamethasone and Dexamethasone Phosphate Entry into Perilymph Compared for Middle Ear Applications in Guinea Pigs

  2018cites this paper
• Diagnostics and therapy of sudden hearing loss

  2018influential citation
• Diagnostik und Therapie des Hörsturzes

  2017influential citation
• Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial

  2017cites this paper
• Becker Digital

  year unknowncites this paper